We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 119

UK Patents Court judgment in Dr Reddy’s Laboratories v Eli Lilly
  • Bird & Bird
  • United Kingdom
  • December 31 2008

In a judgment handed down in October of this year, the Patents Court (Mr Justice Floyd) upheld EP (UK) 0,454,436 (the “Patent”) which is owned by Eli Lilly and which protects the schizophrenia drug olanzapine


Paedriatric SPC extension: zero or negative term SPCs
  • Bird & Bird
  • European Union, United Kingdom
  • March 11 2009

Zero or negative term SPCs give rise to a unique disunity amongst the granting authorities in the European Member States


ECJ decision in AHP Manufacturing BV v the Bureau voor de Industriele Eigendom (Case C-48207)
  • Bird & Bird
  • European Union
  • October 13 2009

The ECJ has accepted that the holder of a basic patent is entitled to one SPC regardless of whether other SPCs have already been granted to other holders of one or more other basic patents


Patent decisions on patents for chiral compounds
  • Bird & Bird
  • United Kingdom
  • May 13 2009

A chiral compound is one which has at least one asymmetric carbon centre


The Court of Appeal’s recent decision on the parallel import of pharmaceutical products
  • Bird & Bird
  • United Kingdom
  • February 28 2008

Following two preliminary references to the European Court of Justice (“ECJ”), on 21 February 2008, the Court of Appeal handed down the latest decision in the long running pharmaceutical parallel import case of Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited (2008 EWCA Civ 83


Court of Appeal decides “settled” EPO case law trumps UK precedent on Swiss-type claim to a new dosage regime
  • Bird & Bird
  • United Kingdom
  • July 16 2008

The Court of Appeal has decided in the case of Actavis UK Ltd v Merck & Co Inc 2008 EWCA Civ 444, that a Swiss-type claim can be patentable where the novelty is only conferred by a new dosage regime or form of administration of a substance


English Patents Court agrees with Dutch but not German court in Occlutech GmbH v AGA Medical Corp and Another
  • Bird & Bird
  • United Kingdom
  • October 13 2009

The English Patents Court was the third court in Europe to adjudicate on infringement Occlutech GmbH v AGA Medical Corp and Another 2009 EWHC 2013 (Ch


Edwards Lifesciences AG v Cook Biotech Incorporated
  • Bird & Bird
  • United Kingdom
  • July 17 2009

Mr Justice Kitchin handed down a decision only four weeks after the hearing, finding Cook’s patent invalid and not infringed by Edwards’ SAPIEN heart valve


The future of the Belgian kiwi reimbursement model jeopardised by a decision of the Council of State?
  • Bird & Bird
  • Belgium
  • July 17 2009

In 2006, Belgium implemented a procedure for the reimbursement of medicinal products that was inspired by the system applicable in New Zealand, known also as the "kiwi model"


Leo v Sandoz UK Patents Court finds pseudopolymorph patent valid
  • Bird & Bird
  • United Kingdom
  • July 17 2009

In his judgment of 15 May 2009 Mr Justice Floyd considered novelty and obviousness attacks on Leo Pharma’s European Patent (UK) 0,679,154 directed to the monohydrate pseudopolymorph of the vitamin D analogue calcipotriol, which is used in the topical treatment of psoriasis